Transgenomic launches leukodystrophy NGS panel By: MarketMinute.com Stock News July 14, 2015 at 13:19 PM EDT Transgenomic Inc. (Nasdaq: TBIO) launched its Transgenomic Leukodystrophy NGS Panel. Shares of the biotechnology company soared 51 cents to $1.94.